Change of serum prealbumin levels and serum protein markers between egg white powder and casein protein additives in standard enteral feeding formulas in critically ill patients with acute respiratory failure by unknown
RESEARCH Open Access
Change of serum prealbumin levels and
serum protein markers between egg white
powder and casein protein additives in
standard enteral feeding formulas in
critically ill patients with acute respiratory
failure
Rungsun Bhurayanontachai1* and Sunatee Sa-nguansai2
Abstract
Background: Protein deficiency is a major problem in critically ill patients. Egg white powder recently became a
standard additive for protein supplementation in our unit. However, clinical data are not available to support egg
white powder supplementation compared to standard protein casein supplementation. This study aimed to
determine the change of serum prealbumin (PAB) levels of egg white powder compared to casein additive in
standard enteral feeding in critically ill patients with respiratory failure.
Methods: A prospective double-blind, randomized, non-inferiority study was conducted in patients with acute
respiratory failure in the medical intensive care unit and respiratory care unit. These patients randomly received
1500 kcal/day of enteral nutrition support with 40 g/day of protein additives by either egg white protein powder or
casein protein for 7 days. The serum PAB and C-reactive protein (CRP) levels were measured on days 1, 3, 5, and 7.
Repeated-measures ANOVA determined the group effects displayed by serum PAB and CRP levels. p values <0.05
were considered statistically significant.
Results: Thirty-four patients were in two groups: 17 in the casein protein group and 17 in the egg white powder
group. The clinical characteristics, baseline nutritional status, and biochemistries were not significantly different
between the groups. No statistically significant differences were seen in the serum PAB and serum CRP levels
between the two groups. The average mean ± SEM difference of serum PAB level between the groups was
2.3 ± 2.5 mg% (p = 0.58).
Conclusions: The levels of PAB between the egg white protein additive and casein protein additive were not
significantly different and less than the non-inferior margin.
Trial registration: Thai Clinical Trials Registry TCTR20160126002
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Background
Critically ill patients typically develop a catabolic stress
state that results in a systemic inflammatory response.
This response is coupled with complications of increased
infectious morbidity, multiorgan dysfunction, prolonged
hospitalization, and disproportionate mortality. Deliver-
ing early enteral nutrition support is a proactive thera-
peutic strategy that can reduce disease severity and
diminish complications. This also decreased the length
of stay in the intensive care unit (ICU) [1, 2].
In the critical care setting, protein appears to be the
most important macronutrient for wound healing, opti-
mizing immunological function, and maintaining lean
body mass [3, 4]. However, the common enteral formu-
las do not meet the protein requirements that are pro-
portionately higher than energy requirements for most
critically ill patients [5]. According to the American So-
ciety for Parenteral and Enteral Nutrition (ASPEN)
guidelines [6], the protein requirement in a critically ill
adult patient is in the range of 1.2–2.0 g/kg/day or the
presumptive non-protein calories to nitrogen ratio
(NPC:N ratio) is about 70:1 to 100:1. Unfortunately, the
current common standard enteral formulas have a high
NPC:N ratio. Therefore, additional protein supplements
are suggested to provide an adequate amount of protein.
The European Society of Parenteral and Enteral Nutrition
(ESPEN) guidelines suggest that whole-protein formulas,
such as milk protein, egg white protein, and soy protein,
are among the most appropriate supplementations in crit-
ically ill patients in the amount of 1.2–2.0 g/kg/day which
depends on the severity of disease [7].
Cow’s milk protein or casein protein was the standard
protein supplement in our hospital for several years, but
the availability of the product is limited and the cost is
high. As a result, egg white protein powder, which is
used normally in the food industry, was adopted as the
standard additional protein supplementation in our unit
because of good availability and lower cost compared to
other types of protein additives. Furthermore, given that
the levels of biological value (BV) and protein efficiency
ratio (PER) of egg white protein are similar to casein
protein, the benefits of egg white protein may be similar
to the casein protein additive [8–11].
Unfortunately, there is still a lack of clinical data to
confirm the benefits of egg white powder supplementa-
tion compared to the standard additive proteins, such as
whey protein or casein in the critical illness setting.
Therefore, we hypothesized that egg white powder sup-
plementation may provide a level of serum prealbumin
(PAB) which is not inferior to casein protein supplemen-
tation in critically ill patients.
The objective of this study was to determine the
change of the serum PAB levels between an egg white
powder group and a casein protein additive group in a
standard enteral feeding formula in critically ill patients
with acute respiratory failure.
Methods
Study design and population
A prospective double-blind, randomized non-inferiority
study was performed between June 2013 and December
2014 in Songklanagarind Hospital which is a tertiary care
hospital with a 10-bed medical ICU and a 16-bed respira-
tory care unit (RCU). The protocol of this study was ap-
proved by the Faculty of Medicine, Prince of Songkla
University Institutional Review Board (REC 56-393-14-1).
The study protocol was registered in the Thai Clinical Tri-
als Registry (TCTR) and the identification number is
TCTR20160126002. Written or oral informed consent
was given by the patients or next of kin. Eligibility for the
study included patients ≥18 years old with acute respira-
tory failure which required invasive mechanical ventilation
and the initiation of enteral nutrition within 48 h after ad-
mission. Exclusion criteria were an expected time of less
than five consecutive days for nasogastric tube feeding,
patient required top-up parenteral nutrition, morbid obes-
ity (body mass index (BMI) >30 kg/m2), renal failure that
required renal replacement therapy, hepatic dysfunction
(total bilirubin >3 mg%), immune suppressive conditions
(e.g., AIDS, chronic steroid use >2 weeks or on immuno-
suppressive drugs), patients with malignancies who were
receiving chemotherapy or radiation therapy, pregnancy,
and those with a history of egg white allergies.
Nutritional management
Nutren Optimum® (Nestlé Nutrition Company,
Switzerland) is the standard enteral formula in our unit
which contains 1 kcal/mL, protein content of 40 g/
1000 kcal, and has an NPC:N ratio of 120:1. The caloric
supplement was fixed at 1500 kcal/day with a top-up
fixed level of 40 g/day for the additional protein supple-
mentation. Tube feeding began within 48 h after admis-
sion and continued for seven consecutive days via
continuous infusion pumps or bolus feeding. According
to the unit enteral feeding protocol, the caloric supple-
mentation was increased gradually to at least 80 % of the
caloric goal within 24–48 h. Metoclopramide, which is a
prokinetic agent, was administered intravenously to im-
prove gastric emptying in the patients who had a gastric
residual volume greater than 250 mL. The patients
were randomly assigned by a computer-generated
randomization sequence into two groups of additional
protein supplementation. The group assignments were
double-blinded by code protein A and protein B. The
codes were opened by the investigators after finishing all
treatments.
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Data resources and manipulation
Demographics as well as clinical characteristics collected
were sex, age, primary diagnosis, APACHE II score, daily
and accumulative fluid balance, and vasopressor used.
Baseline nutritional status, including BMI, ideal body
weight, estimated energy requirement (25 kcal/kg/day),
and estimated protein requirement (1.5 g/kg/day) were
recorded. Serum PAB was the surrogate of adequate pro-
tein energy supplement in this study which is normally
used in conjunction with C-reactive protein (CRP) to as-
sess whether the changes in PAB represent adequate
protein caloric support or changes in inflammation. The
baseline blood chemistries (i.e., serum albumin, BUN,
creatinine, liver function test, and zinc level) were also
recorded before the beginning of the first day of enteral
feeding.
Outcome variables measurement
The primary endpoint of the study was the change of
serum PAB and serum CRP levels in 7 days of nutrition
supplementation. Blood samples for PAB and CRP levels
were consecutively collected on days 1, 3, 5, and 7 of en-
teric feeding.
Statistical analysis
In this non-inferiority study, we postulated that serum
PAB levels in the egg white protein group would be
non-inferior to the casein protein group by a presump-
tive non-inferior margin of 5 mg%. We calculated that
17 patients per additive protein group would provide a
minimum power of 80 % to determine the non-inferior
margin of a 5 mg% using a one-sided α of 0.05. Continu-
ous data were expressed as mean and standard error of
the mean (SEM). Categorical data were expressed as
number and percentage. An independent t test was used
to compare continuous demographic variables for each
treatment group. Fisher’s exact test was used to compare
category demographic variables for each treatment
group. Repeated-measures ANOVA was used to deter-
mine the group effects displayed by the serum PAB and
CRP levels. A post hoc analysis of the linear regression
model was performed to determine the changes in PAB
reflective of adequate caloric and protein support or
changes in inflammatory responses. The results were
considered statistically significant when the p value was
less than 0.05. Statistical analysis was computed by
SPSS® statistical package version 12.
Results
Patient characteristics
Of the 42 patients enrolled, eight patients were excluded:
four in the casein protein group and four in the egg
white powder group. The excluded cases were one case
in the casein protein group that had an expected period
of less than 5 days of enteral feeding, one case in the egg
white powder group that had a change in parenteral nu-
trition support, one case in the egg white powder group
that required renal replacement therapy, and five cases
of death (three in the casein protein group and two in
the egg white powder group).
Thirty-four patients were eventually obtained for per-
protocol analysis (17 in the casein protein group and 17
in the egg white powder group) (Fig. 1). Demographics,
clinical characteristics, baseline nutrition assessments,
and biochemistry data in the two groups were consid-
ered homogeneous (Table 1). The majority of primary
diagnoses were respiratory, cardiac, and neurological
problems. One patient in the casein protein group was
complicated by acute respiratory distress syndrome. Two
cases were diagnosed as sepsis before recruitment into
the study.
According to the severity of disease, the APACHE II
scores in both groups were classified as moderately se-
vere illness concomitant with a significantly high level of
baseline serum CRP. Average accumulative fluid bal-
ances, average daily dose of norepinephrine, and average
caloric and protein intake were not significantly different
between the two groups. The average BMI was in the
normal range. The daily average fluid balance and daily
average norepinephrine requirement in egg white pro-
tein group were higher than those in the casein protein
group, but they were not statistically significant
(Table 2).
In both groups, the actual caloric intake as well as pro-
tein intake achieved 80 % of target within 72 h after en-
teral feeding initiation. The mean percentages ± SEM of
the actual caloric intake during the study period were
93.5 ± 2.3 % in the casein protein supplementation group
and 96.9 ± 1.6 % in the egg white protein powder supple-
mentation group. In addition, the mean ± SEM actual
protein intakes in the casein protein additive and egg
white protein additive groups were 1.7 ± 0.1 and 1.9 ±
0.1 g/kg/day, respectively.
Changes of serum PAB and CRP levels
The daily changes of the serum PAB and CRP levels in
each group and between the groups are shown in Ta-
bles 3 and 4, respectively. The changes of serum PAB
and CRP in the casein protein additive group were not
significantly different from day 1 to day 7, but the serum
CRP levels in the egg white protein additive group de-
creased significantly from day 1 to day 7.
Although the serum PAB essentially increased in both
groups, no statistically significant difference in the serum
PAB between the two groups was seen on days 1, 3, 5,
and 7 (Table 3). The average mean ± SEM difference of
the serum PAB between the two groups was 2.3 ±
2.5 mg%, which was less than the postulated non-
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inferior margin of the study (p = 0.58). In addition, the
serum CRP indicated a decreasing trend in both groups
but no statistically significant difference between the
groups was found (Table 4).
We performed a post hoc analysis of the linear regres-
sion model to determine the changes in PAB reflective
of adequate caloric and protein support or changes in
inflammatory responses. Apparently, the change in
serum CRP was the only independent factor to predict
changes in the serum PAB in all cases (adjusted odds ra-
tio (OR), −0.53, 95 % CI −0.96 to −0.23, p = 0.002) and
in the casein protein additive group (adjusted OR −0.87,
95 % CI −1.16 to −0.60, p < 0.001). No correlation was
found to predict changes in PAB from the change in
serum CRP in the egg white protein group (adjusted OR
−0.38, 95 % CI −1.53 to 0.46, p = 0.26). Furthermore,
changes in both caloric and protein intakes were not in-
dependent factors to predict changes in the serum PAB
(adjusted OR 0.47, 95 % CI −0.04 to 0.02, p = 0.18 and
adjusted OR −0.39, 95 % CI −0.26 to 0.03, p = 0.26).
Discussion
A caloric goal of 25 kcal/kg/day and a protein goal in
the range of 1.2–2.0 g/kg/day were suggested according
to the recent standard recommendations of caloric and
protein intake in critically ill circumstances [6]. Top-up
proteins, for example, milk protein, egg white protein,
and soy protein, are among the most appropriate supple-
mentations in critically ill patients according to the re-
cent ESPEN guideline [7].
Some experts suggested that the biological value (BV)
of protein and protein efficiency ratio (PER) be consid-
ered to select the appropriate type of protein supple-
mentation [9, 12, 13]. Biological value of protein is a
measure of the proportion of absorbed protein that can
be used in protein synthesis in the cells of the human
body. When a protein contains the amount of essential
amino acids equivalent to requirement, the BV of pro-
tein is significantly high [14]. In addition, the PER is the
ratio of grams of body weight gain to the grams of pro-
tein consumed [9]. Animal protein apparently gives a
higher BV and PER than plant protein. Whey protein is
classified as the highest in both BV and PER, followed by
whole egg protein, casein protein, and egg white protein
[9, 11]. However, the clinical evidence of comparing spe-
cific types of protein is limited. In a small randomized
study of whey protein and casein protein supplement in
acute stroke patients, the whey protein additive may de-
crease inflammation and increase antioxidant levels in
patients with acute stroke compared to casein protein
additive [15].
In developing countries, protein supplements are lim-
ited in supply and they are costly. Casein protein addi-
tive was used regularly in our unit as a standard protein
additive for a period of time, but the availability was lim-
ited and the cost was high. For this reason, protein sup-
plementation in critically ill patients was possibly
inadequate. Egg white protein powder, which is normally
used in the food industry, is widely available, is less
costly, and possibly gives a similar BV and PER to casein
protein. As a result, this type of protein additive has
been suggested as a substitute for casein protein additive
in our unit. This study was conducted to determine the
effect of serum protein marker change between egg
white protein additive and casein additive in critically ill
patients by the non-inferiority fashion.
The results of this study demonstrated that the incre-
ment of serum PAB level in egg white protein additive
was not inferior to the casein protein additive group (p
= 0.58) with an average mean ± SEM difference of 2.3 ±
2.5 mg%. However, the increments of PAB within both
groups were not different from day 1 to day 7. The low
Assessed for eligibility (n=42)
Randomization (n=42)
Casein group: n=21
- 1 excluded due to less than
5 days of EN




Egg white powder group: n=21
- 1 excluded due to change to PN
- 1 excluded due to plan of RRT
- 2 excluded due to death during 
the study
Casein protein group: n=17
Follow-up
(n=34) Egg white powder group: n=17
Casein protein group: n=17
Analysis
(n=34) Egg white powder group: n=17
Fig. 1 Study overview
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increments in the serum PAB levels were lower than the
physiological expectations which were possibly affected
by the catabolic stress state in those with critical ill-
nesses. From our findings, the positive accumulative
daily fluid balance and the amount of norepinephrine re-
quirement indicated incomplete resolution of catabolic
responses during the study period. Furthermore, the
large variability of the pathology of acute respiratory fail-
ure in this study may influence the alteration of serum
PAB. The small sample sizes of each pathology may lead
to an unconcluded definite outcome of this trial.
From a recent study, an 80 % of caloric intake to cal-
oric goal demonstrated significantly better outcomes
that included ICU morbidity and mortality [16]. The ad-
equacy of caloric and protein support in this study was
evidenced by the average percentage of caloric intake to
caloric goal greater than 90 % in both groups, and the
range of protein intake in both groups was 1.7–1.9 g/kg/
day. Therefore, the influence of serum protein markers
by the amount of protein calories could be
demonstrated.
PAB is normally suggested as a marker of adequate
caloric and protein support in preference to other serum
protein markers such as serum albumin and serum
transferrin [17]. Moreover, the PAB level correlates well
with clinical outcomes, has a short half-life of about
2.5 days, is less affected by liver disease, and is not af-
fected by hydration status. In patients who receive ad-
equate caloric and protein supplementation, the PAB
level should rise by 2 mg% per day and then return to
Table 1 Demographic, clinical characteristics, baseline nutritional status, and biochemistries in the two groups
Characteristics Casein group (n = 17) Egg white powder group (n = 17) p value
Male sex 52.9 % (9/17) 47.1 % (8/17) 0.73
Age (year) 73.2 ± 3.7 70.3 ± 3.8 0.59
Primary diagnosis (%) 0.31
Respiratory causes 76.5 % (13/17) 58.8 % (10/17)
Cardiovascular causes 17.7 % (3/17) 11.8 % (2/17)
Neurological causes 5.9 % (1/17) 17.7 % (3/17)
Sepsis/septic shock 0 11.8 % (2/17)
Presence of ARDS (%) 5.9 % (1/17) 0 % (0/17) 0.30
APACHE II score 17.9 ± 1.0 18.6 ± 1.1 0.67
Norepinephrine dose (μg/kg/min) 0.008 ± 0.006 0.024 ± 0.011 0.21
Height (cm) 159.4 ± 2.3 155.9 ± 2.4 0.31
Ideal body weight (kg) 54.2 ± 2.5 50.8 ± 2.7 0.36
BMI (kg/m2) 21.3 ± 0.76 21.8 ± 0.9 0.70
Estimated energy requirement (kcal/day) 1626.4 ± 73.7 1523.7 ± 81.9 0.36
Estimated protein requirement (g/day) 81.3 ± 3.7 76.2 ± 4.1 0.36
Average accumulative fluid balance (mL) 4406.9 ± 546.6 6296.1 ± 1420.9 0.20
Average caloric intake (kcal/day) 1402.3 ± 34.7 1453.1 ± 24.3 0.25
Average protein intake (g/day) 89.3 ± 2.6 93.6 ± 1.4 0.17
Average percentage of caloric intake/caloric goal (%) 93.5 ± 2.3 96.9 ± 1.6 0.26
Average gram protein intake (g/kg/day) 1.7 ± 0.1 1.9 ± 0.1 0.19
CRP (mg%) 7.2 ± 1.4 7.3 ± 1.3 0.96
Albumin (g%) 2.7 ± 0.2 2.9 ± 0.1 0.48
Prealbumin (mg%) 13.7 ± 1.7 11.1 ± 1.5 0.25
BUN (mg%) 33.6 ± 5.3 33.8 ± 5.5 0.98
Creatinine (mg%) 1.3 ± 0.2 1.2 ± 0.2 0.91
Total bilirubin (mg%) 0.4 ± 0.1 0.7 ± 0.2 0.12
AST (U/L) 41.3 ± 4.2 65.2 ± 10.8 0.06
ALT (U/L) 34.3 ± 8.9 59.7 ± 19.5 0.27
Zinc level (mg/L) 0.5 ± 0.1 0.5 ± 0.1 0.21
All continuous data are expressed as mean ± SEM. All categorical data are expressed as percentage.
ARDS acute respiratory distress syndrome, APACHE II acute physiology and chronic health evaluation, BMI body mass index, BUN blood urea nitrogen, AST
aspartate aminotransferase, ALT alanine aminotransferase
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normal within 4–8 days [18]. However, numerous factors
may interfere with the level of serum PAB, for example,
severe renal failure, corticosteroid use, oral contracep-
tion use, significant hyperglycemia, and hemodialysis.
Furthermore, the level of serum PAB may be signifi-
cantly reduced by the reduction of PAB synthesis in
acute inflammatory state [12, 19]. Therefore, CRP is the
most popular inflammatory protein marker generally
used in conjunction with PAB to determine the changes
in PAB reflective of adequate caloric support or changes
in inflammatory responses.
CRP is a common protein marker for inflammation
which rapidly changes in the systemic inflammatory
status in both acute and chronic responses. The half-
life of CRP is approximately 19 h and can change
rapidly with the level of inflammatory response. How-
ever, the limitations of using CRP to determine the
severity and stage of inflammatory responses were re-
ported [20–22].
From a recent retrospective study, the change in
serum CRP was the only independent factor of serum
PAB change rather than the change of nutrition intake.
Therefore, the serum PAB may be influenced by inflam-
matory responses rather than adequate caloric and pro-
tein support [23]. However, the caloric and protein
intake in that retrospective study was only 50–60 % of
caloric goal, which was significantly lower than our
study and could be a limitation to find the correlation.
Our study also demonstrated the improvement of in-
flammatory markers by egg white protein supplementa-
tion. The mean serum CRP level decreased significantly
in day 7 compared to day 1 in the egg white powder
group, determined by repeated-measures ANOVA (p =
0.01). The improvement of the oxidative stress may the-
oretically improve the balance of protein anabolism/ca-
tabolism with comprehensive benefits in critically ill
patients. The additional protein supplementation, espe-
cially cysteine-rich egg white protein, increased the
Table 2 Average daily fluid balance and average daily dose of norepinephrine between the two groups
Day Casein protein group (n = 17) Egg white powder group (n = 17) p value
Average daily fluid balance (mL/day)
Day 1 773.6 ± 151.2 1291.7 ± 332.1 0.17
Day 2 758.2 ± 155.5 766 ± 232.1 0.98
Day 3 736.3 ± 141.8 1039.7 ± 285.9 0.35
Day 4 527.4 ± 190.4 641.5 ± 229.7 0.71
Day 5 790.3 ± 157.7 872.4 ± 216.1 0.76
Day 6 435.4 ± 174.8 754.6 ± 281.3 0.33
Day 7 385.8 ± 157.1 559.2 ± 215.7 0.51
Total fluid balance (mL) 4406.9 ± 546.6 6296.1 ± 1420.9 0.20
Average daily dose of norepinephrine (μg/kg/min)
Day 1 0.008 ± 0.006 0.025 ± 0.011 0.21
Day 2 0.004 ± 0.004 0.002 ± 0.002 0.82
Day 3 0.005 ± 0.005 0.008 ± 0.006 0.72
Day 4 0.008 ± 0.005 0.159 ± 0.008 0.47
Day 5 0.019 ± 0.015 0.012 ± 0.012 0.75
Day 6 0.034 ± 0.03 0.0 ± 0.0 0.27
Day 7 0.034 ± 0.03 0.0 ± 0.0 0.27
All data are expressed as mean ± SEM
Table 3 Serum PAB levels between the two groups on days 1, 3, 5, and 7
Day Casein protein group (n = 17) Egg white powder group (n = 17) p value
(between
groups)
Biochemical values p value (compared to day 1) Biochemical values p value (compared to day 1)
Serum PAB level (mg %)
Day 1 13.7 ± 1.7 11.1 ± 1.5 0.25
Day 3 14.3 ± 1.8 0.29 11.4 ± 1.6 0.52 0.23
Day 5 14.2 ± 1.9 0.64 11.8 ± 1.6 0.46 0.33
Day 7 15.8 ± 1.9 0.13 14.6 ± 2.1 0.21 0.70
All data are expressed as mean ± SEM; repeated-measures ANOVA model was applied
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amounts of substrate for the synthesis of glutathione [24].
The increment of glutathione, which is a natural antioxi-
dant, will attenuate the severity of inflammatory responses
and result in a lower serum CRP level. However, the dec-
rement of serum CRP in our study could not be distin-
guished between the recoveries of illness from the effect
of nutritional therapy or the specific type of protein. The
correlation of the egg white protein or other specific types
of protein additives and the alteration of inflammatory
markers may require a larger study.
To determine the changes in serum PAB reflective of
adequate caloric and protein support or changes in in-
flammatory responses, the post hoc analysis by the linear
regression model indicated the changes of caloric and
protein support were not predictors for serum PAB
changes. In addition, the change of serum CRP as a sur-
rogate of inflammation may not correlate totally to the
change of serum PAB because this correlation was found
only in the casein group and not in the egg white pro-
tein group. There are some other explanations. First, this
study was not designed to determine the regression ana-
lysis, so the sample sizing may not be adequate to detect
the correlation. Second, other factors which could not
be measured in this study due to limited resources were
the blood level interleukin, tumor necrosis factor, and
other inflammatory cytokines which may influence the
changes of PAB over time.
Although previous studies suggested PAB as a surro-
gate of adequate caloric and protein intake in critically
ill patients [17, 25, 26], our study may contradict that
suggestion. Other serum protein markers, such as serum
free amino acids [27, 28] or the measurement of muscle
mass and function [29, 30], could be used as a surrogate
in further protein supplement studies in critically ill pa-
tients. Although, improvements of biochemistry results
were shown in this study, the clinical outcomes still need
to be confirmed.
Apart from those limitations, our study was the first
prospective double-blinded randomized control study to
compare the benefits of two types of protein supplemen-
tation which included casein protein and egg white pro-
tein in a critically ill cohort. The inclusion and exclusion
criteria were rigid which diminished bias and confound-
ing factors for changes in serum protein markers by dis-
ease conditions and treatment modalities. This study
was intentionally conducted to solve the real-life uncer-
tainties that occur during daily clinical practice in caring
for critically ill patients. The results of this type of study
may ensure the ongoing process of care and might be
applicable in regions of limited resources.
Although the serum PAB may not be an appropriate
serum protein marker to determine the benefit of the
type of protein supplementation, an adequate dosage of
either casein protein or egg white protein may be benefi-
cial to maintain the level of specific serum protein
markers in critically ill patients.
Conclusions
Although the levels of PAB between the egg white pro-
tein additive and casein protein additive were not signifi-
cantly different and less than the non-inferior margin of
5 mg%, this result cannot be totally concluded because
no significant correlation in the change of caloric or pro-
tein intake to predict a change in serum PAB was de-
tected. A further study to determine another type of
serum protein marker or muscular functional test needs
to be performed.
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